Commercial Partners 2018

If you are interested in sponsoring the Global Drug Delivery and Formulation Summit please contact:

Tel:+ 44 (0)20 3874 9205


Agilent Technologies Inc. is a technology leader in life sciences and diagnostics. Agilent has a strong focus on the Pharmaceutical space and provides analytical solutions to researchers ranging from sample prep to analysis.

The company has about 12500 employees globally and had revenues of $4.2 billion in fiscal year 2016.


Profile TBC


Capsugel is a global leader in delivering high-quality, innovative dosage forms and solutions to its customers in the health care industry. The company Hard Capsule business offers customers the broadest portfolio of gelatin, vegetarian, and other specialized capsule technologies. Capsugel Dosage Form Solutions (DFS) business utilizes an array of proprietary technologies and specialized manufacturing capabilities to solve customers most pressing product development challenges, including bioavailability enhancement, modified release, abuse deterrence, biotherapeutic processing, and inhalation formulation. The company’s fast-to-clinic program streamlines product development from pre-formulation through clinical and commercial supply for finished dosage forms.

For more information, visit

DFE Pharma

DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder formulations with a heritage in lactose, starch and superdisintegrants. With the addition of MCC to our portfolio DFE Pharma uniquely offers world's main excipient categories, unlocking potential synergies for you to increase your efficiency. Contact us on

Dow Pharma & Medical

Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and extending product life-cycles. Whether you are creating modified release medicines, seeking to enhance the solubility of Active Pharmaceutical Ingredients for therapeutic effect, or simply looking for efficient wound care through soft skin adhesives, we can take you there.

Dow will highlight specific solutions on solubility enhancement:

– New possibilities using AFFINISOL™ excipients – exploring a platform of tailored polymers for solubility enhancement

Well-known brands for:

  • Solubility Enhancement
  • Modified Release
  • Taste Masking
  • Tablet or Enteric Coating
  • Binders
  • Stabilizers
  • Rheology Modifiers
  • Adhesives
  • Antifoams and Antifoam Simethicone Emulsions
  • Fluids, Emulsions and Dispersions
  • Topical Excipients
  • Topical Ingredients
  • Rubber and Elastomers
  • Tubing and Molded Assemblies


Profile TBC


Profile TBC

Profile TBC


Hovione is a global company with over 50 years' experience in Active Pharmaceutical Ingredient and Drug Product Intermediate development and compliant manufacture. With FDA inspected sites in U.S., Ireland, Portugal and China, the company offers integrated API and services in contract development and commercial manufacture of custom pharmaceutical molecules and drug product intermediates. Hovione is expert in particle engineering technologies to solve problems like poor bioavailability, patient acceptability or enabling optimal delivery by non-oral routes of administration. In the inhalation area, Hovione is the only independent company offering such a broad range of services. Hovione also undertakes the formulation development and clinical supply of the final dosage form to Phase II.

Leon Nanodrugs

Leon-nanodrugs GmbH (Munich) is a nanotechnology-based drug development company focused on development of novel oral and parenteral formulations and innovative drug combinations.

The proprietary and patent-protected MicroJetReactor Technology by leon-nanodrugs is a bottom-up approach for nano- and microparticle synthesis. Basis of the process is a continuous solvent / non-solvent precipitation that is performed under precisely controlled process conditions.

Build on its “network of expertise”, leon-nanodrugs can provide a 360 degree competence range – from concept to product approval.

Leon-nanodrugs proprietary MJR® Technology offers access to the next generation nano formulated drugs with added patient benefits and economical values for its partners and shareholders.

Losan Pharma

70% of the NCE´s have a certain problem (solubility, stability, bioavailability, variability) which limits their potential use. Losan is a privately owned company and has beside the conventional technologies a broad platform for innovative technologies like (i) Solubilisation technologies such as Nanoparticulate , HME-based or Amorphous Silica formulations with proven in-vivo results, (ii) Pellet/Coating technology for target release formulations (iii) Stick pack technology for high dose and convenience application (iv) OTC innovations. Our strategy is to help companies with the design and solutions of their specific API formulations needs. A strong analytical support (DoE, QbD, ivivc correlation,) completes our approach.

LTS Lohmann

LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch.

The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA.

More than 3,000 patents reinforce the top position of LTS group in development of its technologies.

LTS Lohmann services include:

  • Feasibility studies
  • Full product development
  • Clinical studies phase I-IV
  • Scale-up and process development
  • Commercial manufacturing

For transdermal therapeutic systems, topical patches and oral thin films (OTF)


Profile TBC


Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 8,000 employees across 26 locations around the world, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle.

Through its integrated global network of serving 70 countries, the company meets the needs of a breadth of clients, including pharmaceutical, biotechnology and specialty pharmaceutical companies seeking expertise to bring their drug candidates from pre-clinical stages through clinical trials to commercial production and supply.


Revox Sterilization Solutions

The REVOX® sterilization process uses a room-temperature vaporized peracetic acid (VPA) method that achieves exceptionally low chemical residuals and unsurpassed materials compatibility. The REVOX technology eliminates inefficiencies associated with pre-conditioning and lengthy post sterilization wait times. This allows REVOX to offer manufacturers a quick-turn, off-site sterilization service or cost efficient on-site, in-line processing. With the 3000L machine, or 417L, REVOX enables in-line sterilization, allowing companies to safely and easily integrate sterilization into a lean manufacturing process with no exhaust or other special infrastructure needed. In 2014 a Class II implantable device was granted FDA clearance with the REVOX sterilization process.


ROQUETTE “Improving well-being by offering the best of nature”

A family-owned Group serving customers globally, Roquette is a leader in specialty food ingredients and pharmaceutical excipients. The products and solutions developed by the Group deliver proven technological, nutritional and health benefits precisely tailored to the pharma, nutrition, food and selected industry markets. Roquette’s offer is produced from plant based raw materials such as corn, wheat, potatoes and peas.

Since its foundation over 80 years ago, the Group’s growth has been based on innovation, a passion for the job and a commitment to achieve. Roquette operates in over 100 countries, has a turnover of around 3.3 billion euros and currently employs more than 8,000 people worldwide.

Shin-Etsu Pharma & Food Materials Distribution GmbH

Shin-Etsu PFMD is the distribution organization of Shin-Etsu Chemical Co., Ltd. Japan and SE Tylose, Wiesbaden Germany and is registered in Wiesbaden. It is located at the Industrial Park Kalle-Albert in Wiesbaden. Together with our distributors, we are the exclusive business partners for our customers and multi national key accounts in the pharmaceutical- and the food industry.

SE PFMD manages a regional, centralized warehouse for all products to be able to supply the customers in Europe on short-term base whenever necessary. SE PFMD will manage logistic for customers in other regions independent from Shin-Etsu´s production sites. For our pharma customers we offer with our technical application lab the possibility to optimize their processes if required. Our products are covering a very wide range of applications and they fully comply with FDA, USP/NF, JP and EP requirements.

Pharmaceutical Excipients: Cellulose ether excipient is a pharmacologically inactive substance used as a carrier for the active ingredients in medication.

PHARMACOAT® – Water-Soluble Film Coating Agent
METOLOSE® – Binder and Thickening Agent
METOLOSE® SR – Sustained release agent for hydrophilic matrix system
L-HPC – Disintegrant with Binding Properties, Multifunctional Excipient
HPMCP – Enteric Coating Agent
Shin-Etsu AQOAT® – Enteric Coating Agent, Solid Dispersion Polymer
Tylopur® – Low- and high viscosity Hypromellose


Unchained Labs

Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.

Quotient Clinical

Quotient Clinical is a drug development services provider, focused on helping clients reduce the time and cost of bringing a drug to market. We deliver integrated capabilities including formulation development, GMP drug product manufacturing and clinical pharmacology services to biotech and pharmaceutical clients globally.

We employ over 600 staff and operate from state-of-the-art manufacturing and clinical facilities in the UK and USA. We can support our clients, working under FDA or MHRA guidelines, and offer a full range of support services, from study set-up right through to data analysis and reporting.

Meggle Excipients & Technology

Merck KGaA

Merck KGaA, Darmstadt, Germany, a leading science and technology company in life science, offers products used by pharma and biopharma companies to develop and manufacture drugs safely and efficiently. With the acquisition of Sigma-Aldrich, we now have the largest offering of products and services for formulations, actives and biotechnology processes. We provide excipients, APIs, complex API manufacturing services and critical raw materials to support all stages of the drug manufacturing process from research to industrial-scale production and quality control. Our products meet the highest purity standards with extensive documentation and services to assure regulatory compliance.

W.L. Gore & Associates, Inc

Profile TBC

Commercial Partners: